{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:43:23Z","timestamp":1773409403932,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4623,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[1995,11]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> Human chorionic gonadotropin (hCG)\u2010like molecules have been reported to be elevated in a substantial fraction of serum samples from patients with various gynaecologic tumours and have been discussed as possible markers in these malignancies. Employing highly sensitive and specific immunoradio\u2010metric assays, we determined total hCG\u2010related immunoreactivity (hCG\/hCG\u03b2), as well as free \u03b1\u2010subunit (\u03b1\u2010SU), common to all glycoprotein hormones, in serum (<jats:italic>n<\/jats:italic>= 106) and malignant effusions (<jats:italic>n<\/jats:italic>= 26) of women with gynaecologic malignancies. For comparison, we also measured hCG\/hCG\u03b2 in nonmalignant ascitic fluids (<jats:italic>n<\/jats:italic>= 21). HCG\/hCGd\u0303 serum levels were elevated (&gt;5 IU L<jats:sup>\u20101<\/jats:sup>) in 39 of 106 patients (37%) with gynaecologic malignancies, whereas free \u03b1\u2010SU was above normal range only in seven (6.6%). Frequencies of hCG\/hCG\u03b2 elevations were similar in women with endometrial (<jats:italic>n<\/jats:italic>= 39), cervical (<jats:italic>n<\/jats:italic>= 40) and ovarian (<jats:italic>n<\/jats:italic>= 27) cancer, being 30%, 35% and 41%, respectively. In malignant ascites (<jats:italic>n<\/jats:italic>= 15) and tumour cyst fluids (<jats:italic>n<\/jats:italic>= 11) of patients with ovarian cancer, hCG\/ hCG\u03b2 concentrations were significantly higher than in the corresponding serum samples and benign ascitic samples. Free \u03b1\u2010SU, on the other hand, was increased in only one of 26 malignant effusions. In conclusion, hCG\/hCG\u03b2 is frequently elevated in serum of patients with endometrial, cervical and ovarian cancer and may serve as a tumour marker in these malignancies, particularly in patients where other markers are negative. In this respect, analysis of ascitic or tumour cyst fluids may be of higher diagnostic value as serum measurements.<\/jats:p>","DOI":"10.1111\/j.1365-2362.1995.tb01697.x","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T12:08:50Z","timestamp":1206014930000},"page":"867-873","source":"Crossref","is-referenced-by-count":26,"title":["Measurement of human chorionic gonadotropin\u2010related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies"],"prefix":"10.1111","volume":"25","author":[{"given":"M.","family":"GROSSMANN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"HOERMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"GOCZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"OTT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"BERGER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"MANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.50.070181.002341"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0021-9258(19)50712-8","article-title":"Identification of the transcriptionally active genes of the chorionic gonadotropin \u03b2 gene cluster in vivo","volume":"267","author":"Bo M.","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/cncr.1980.45.s7.1755","article-title":"The role of biologic tumor markers in testicular cancer","volume":"45","author":"Javadpour N.","year":"1980","journal-title":"Cancer"},{"key":"e_1_2_1_5_2","first-page":"327","article-title":"Germ cell tumours: a collaborative review","volume":"1","author":"Norgaard\u2010Pedersen B.","year":"1980","journal-title":"Oncodevelopmental Biology and Medicine"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ssu.2980060604"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197811)42:5<2328::AID-CNCR2820420533>3.0.CO;2-U"},{"key":"e_1_2_1_8_2","first-page":"81","article-title":"Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment","volume":"65","author":"Blackman MR","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800515)45:10<2583::AID-CNCR2820451018>3.0.CO;2-W"},{"key":"e_1_2_1_10_2","first-page":"3901","article-title":"Free human chorionic gonadotropin \u03b2 subunit in gonadal and nongonadal neoplasms","volume":"52","author":"Marcillac I.","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_11_2","first-page":"112","article-title":"Clinical utility of human chorionic gonadotropin and \u03b1\u2010subunit measurements","volume":"60","author":"Hussa RO.","year":"1982","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_12_2","first-page":"103","article-title":"The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant disease","volume":"15","author":"Birkenfeld S.","year":"1989","journal-title":"Eur J Surg Oncol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(84)90042-5"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1250301"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-5-2351"},{"key":"e_1_2_1_16_2","first-page":"204","article-title":"International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis","volume":"3","year":"1965","journal-title":"J Int Fed Gynec Obstet"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/clinchem\/36.2.234","article-title":"Testicular cancer secretes intact human choriogonadotropin (hCG) and its free \u03b2\u2010subunit: evidence that hCG (+hCG\u2010\u03b2) assays are the most reliable in diagnosis and follow\u2010up","volume":"36","author":"Sailer B.","year":"1990","journal-title":"Clin Chem"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinchem\/38.3.370","article-title":"Free \u03b1\u2010subunit, free \u03b2\u2010subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients","volume":"38","author":"Madersbacher S.","year":"1992","journal-title":"Clin Chem"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19881201)62:11<2378::AID-CNCR2820621121>3.0.CO;2-G"},{"key":"e_1_2_1_20_2","first-page":"4628","article-title":"Elevation of free \u03b2\u2010subunit of human choriogonadotropin and core \u03b2 fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease","volume":"52","author":"Alfthan H.","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197709152971101"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910220408"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197911)44:5<1644::AID-CNCR2820440517>3.0.CO;2-B"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800301)45:5<948::AID-CNCR2820450519>3.0.CO;2-Q"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890401)63:7<1337::AID-CNCR2820630719>3.0.CO;2-J"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a136832"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000292728"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(84)90188-1"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/88.4.467"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(88)90273-9"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19811201)48:11<2475::AID-CNCR2820481121>3.0.CO;2-Y"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800715)46:2<355::AID-CNCR2820460224>3.0.CO;2-U"},{"key":"e_1_2_1_33_2","first-page":"1520","article-title":"Immunoreactive human chorionic gonadotropin and its free beta\u2010subunit in serum and ascites of patients with malignant tumors","volume":"52","author":"Hoermann R.","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_34_2","first-page":"339","article-title":"CA 125 in peritoneal washings and fluid: correlation with plasma CA 125 and peritoneal cytology","volume":"73","author":"Schwartz PE","year":"1989","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO;2-I"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90165-H"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820215)49:4<722::AID-CNCR2820490421>3.0.CO;2-C"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.1995.tb01697.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.1995.tb01697.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T20:15:03Z","timestamp":1698264903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.1995.tb01697.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["10.1111\/j.1365-2362.1995.tb01697.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.1995.tb01697.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}